Bill Text: HI HB2391 | 2018 | Regular Session | Amended
Bill Title: Relating To The Uniform Controlled Substances Act.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Engrossed - Dead) 2018-03-21 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDC. [HB2391 Detail]
Download: Hawaii-2018-HB2391-Amended.html
|
HOUSE OF REPRESENTATIVES |
H.B. NO. |
2391 |
|
TWENTY-NINTH LEGISLATURE, 2018 |
H.D. 2 |
|
|
STATE OF HAWAII |
S.D. 1 |
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION
1. Section 329-104, Hawaii Revised
Statutes, is amended by amending subsection (c) to read as follows:
"(c) This section shall not prevent the
disclosure, at the discretion of the administrator, of investigative
information to:
(1) Law enforcement officers, investigative agents
of federal, state, or county law enforcement or regulatory agencies, United
States attorneys, county prosecuting attorneys, or the attorney general;
provided that the administrator has reasonable grounds to believe that the disclosure
of any information collected under this part is in furtherance of an ongoing
criminal or regulatory investigation or prosecution;
(2) Registrants authorized under chapters 448,
453, and 463E who are registered to administer, prescribe, or dispense controlled
substances and their practitioner delegate; provided that the information
disclosed relates only to the registrant's own patient;
(3) Pharmacists or pharmacist delegates, employed
by a pharmacy registered under section 329-32, who request prescription
information about a customer relating to a violation or possible violation of
this chapter;
(4) Other state-authorized governmental
prescription-monitoring programs;
(5) The chief medical examiner or licensed
physician designee who requests information and certifies the request is for
the purpose of investigating the death of an individual;
(6) Qualified personnel for the purpose of bona
fide research or education; provided that data elements that would reasonably
identify a specific recipient, prescriber, or dispenser shall be deleted or
redacted from the information prior to disclosure; provided further that
release of the information may be made only pursuant to a written agreement
between qualified personnel and the administrator in order to ensure compliance
with this subsection; [and]
(7) Other entities or individuals authorized by
the administrator to assist the program with projects that enhance the
electronic prescription accountability system[.]; and
(8) Authorized employees of the department of
health alcohol and drug abuse division and the emergency medical services and
injury prevention system branch.
Information disclosed to a registrant, pharmacist,
or authorized government agency under this section shall be transmitted by a
secure means determined by the designated agency."
SECTION 2. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION
3. This Act shall take effect on July 1,
2018.
Report Title:
Electronic Prescription Accountability System; Disclosure
Description:
Authorizes disclosure of investigative information collected by the Electronic Prescription Accountability System to authorized employees of the Department of Health's Alcohol and Drug Abuse Division and Emergency Medical Services and Injury Prevention System Branch. (SD1)
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.
